62 reports of this reaction
1.4% of all ALUMINUM HYDROXIDE reports
#11 most reported adverse reaction
DIABETES MELLITUS is the #11 most commonly reported adverse reaction for ALUMINUM HYDROXIDE, manufactured by Rugby Laboratories. There are 62 FDA adverse event reports linking ALUMINUM HYDROXIDE to DIABETES MELLITUS. This represents approximately 1.4% of all 4,296 adverse event reports for this drug.
Patients taking ALUMINUM HYDROXIDE who experience diabetes mellitus should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DIABETES MELLITUS is a less commonly reported adverse event for ALUMINUM HYDROXIDE, but still significant enough to appear in the safety profile.
In addition to diabetes mellitus, the following adverse reactions have been reported for ALUMINUM HYDROXIDE:
The following drugs have also been linked to diabetes mellitus in FDA adverse event reports:
DIABETES MELLITUS has been reported as an adverse event in 62 FDA reports for ALUMINUM HYDROXIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DIABETES MELLITUS accounts for approximately 1.4% of all adverse event reports for ALUMINUM HYDROXIDE, making it a notable side effect.
If you experience diabetes mellitus while taking ALUMINUM HYDROXIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.